DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Buller HR, Lensing AW, Prins MH , et al; Einstein-DVT Dose-Ranging Study investigators.
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Blood 2008;
112 (6) 2242-2247
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.